Medicare Stage B Heart Failure Criteria
Stage B heart failure (pre-heart failure) is defined as structural heart disease without current or previous symptoms or signs of heart failure. 1
Definition and Diagnostic Criteria for Stage B Heart Failure
Stage B heart failure includes patients who meet the following criteria:
- No current or previous symptoms or signs of heart failure 1
- Evidence of at least one of the following: 1
- Structural heart disease
- Reduced left or right ventricular systolic function
- Reduced ejection fraction or reduced strain
- Ventricular hypertrophy
- Chamber enlargement
- Wall motion abnormalities
- Valvular heart disease
- Evidence of increased filling pressures
- By invasive hemodynamic measurements
- By noninvasive imaging suggesting elevated filling pressures
- Risk factors with increased natriuretic peptide levels or persistently elevated cardiac troponin in the absence of competing diagnoses 1
- Structural heart disease
Common Examples of Stage B Heart Failure
Patients with Stage B heart failure commonly include those with: 1
- Previous myocardial infarction 1
- Known structural heart disease 1
- Asymptomatic valvular disease 1
- LV hypertrophy or LV dysfunction without symptoms 1
Clinical Significance and Management
Stage B heart failure represents a critical opportunity for prevention of symptomatic heart failure. Management recommendations include:
- ACE inhibitors or ARBs in appropriate patients with a history of MI and reduced EF to prevent progression to symptomatic heart failure 1
- Evidence-based beta blockers in patients with MI and reduced EF 1
- Statins in patients with a history of MI to prevent heart failure 1
- Blood pressure control according to published guidelines 1
- Implantable cardioverter-defibrillators may be reasonable in selected patients (e.g., those with asymptomatic ischemic cardiomyopathy who are at least 40 days post-MI, have LVEF ≤30%, and are on guideline-directed medical therapy) 1
Evolution of Stage B Criteria
It's important to note that the definition of Stage B heart failure has evolved over time:
- The 2005 ACC/AHA guidelines defined Stage B simply as "structural heart disease but without signs or symptoms of HF" 1
- The 2022 ACC/AHA/HFSA guidelines expanded the definition to include objective evidence of increased filling pressures and biomarker criteria 1
Clinical Pearls and Pitfalls
- Avoid nondihydropyridine calcium channel blockers with negative inotropic effects in patients with low LVEF, as they may be harmful 1
- Stage B represents a critical intervention point where appropriate medical therapy can prevent progression to symptomatic heart failure (Stage C) 1
- Regular monitoring of patients with Stage B heart failure is essential, as they remain at high risk for developing symptomatic heart failure 1
- The trajectory of LVEF over time is important to evaluate, as patients with mildly reduced EF may be in a dynamic trajectory toward improvement or deterioration 1
Relationship to Other Classification Systems
Stage B heart failure typically includes patients who would be classified as NYHA Class I (no limitations on physical activity) if they have structural heart disease 1